12-32850765-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001005242.3(PKP2):c.1378+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000206 in 1,457,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001005242.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1457724Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 725404
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 9 Pathogenic:1
This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 923177). This variant is also known as D460fsX464. Disruption of this splice site has been observed in individuals with arrhythmogenic right ventricular cardiomyopathy (ARVC) (PMID: 18662195, 20400443). This sequence change affects a donor splice site in intron 5 of the PKP2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PKP2 are known to be pathogenic (PMID: 15489853, 23911551). -
Cardiomyopathy Pathogenic:1
This variant causes a G>A nucleotide substitution at the +1 position of intron 5 of the PKP2 gene. Splice site prediction tools predict that this variant may have a significant impact on RNA splicing. Although functional studies have not been performed for this variant, this variant is predicted to result in an absent or non-functional protein product. This variant has not been reported in an individual affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 28523642). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of PKP2 function is a known mechanism of disease. Based on the available evidence, this variant is classified as Likely Pathogenic. -
not provided Pathogenic:1
Identified in a 14 year old patient with arrhythmogenic cardiomyopathy (ACM), who also harbored a second PKP2 variant (c.1181T>C) in trans, who underwent heart transplant and died due to heart failure at age 18; this individual's unaffected father and paternal aunt were heterozygous for the c.1378+1G>A variant in PKP2 (PMID: 30830208); Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies suggest a damaging effect by dramatically reduced expression of connexin34, though the variant does not appear to alter the organization of intercalated disk proteins (PMID: 18662195); Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31402444, 35819174, 32522011, 28523642, 18662195, 30830208) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at